Keywords: arqule, 1st-qtr, loss, narrows, 9m, drugmaker, first-quarter
ArQule's 1st-qtr loss narrows to $13.9M
Article | 26 May 2008
US drugmaker ArQule's first-quarter 2008 net loss totaled $13.9 million, or $0.32 per share, versus a net loss of $14.5 million, or $0.40 per share, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
